Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

The rise of search marketing in healthcare

Search is ubiquitous, but what is pharma doing to assist in the user journey?

- PMLiVE

NHS gears up for winter comms push

Urges public to visit pharmacists for winter ailments and promotes the flu jab

- PMLiVE

UCB staff high five for arthritis

Firm supports the World Arthritis Day social media campaign

- PMLiVE

ResearchKit picked for autism, epilepsy and melanoma studies

Continues Apple's exploration of its iPhone software as amedical research tool

- PMLiVE

GSK and J&J back new UK dementia discovery fund

Pharma giants collaborate with government to find new treatments

National Institute for Health and Care Excellence NICE logo

NICE backs use of anti-cholesterol drug Ezetrol

Draft guidance reflects 'greater emphasis on managing CVD risk'

Biogen Idec building

Biogen cuts workforce and culls pipeline projects

Attempts to make major cost savings as MS drug sales slow

- PMLiVE

Valeant shares plummet on claims of inflated revenues

California lawsuit raises questions about relationship with Philidor Rx

Merck & Co reorganises its HCP communities, hands Univadis to Physicians Interactive

Physicians Interactive outlines globalambitions for its newly-expanded network

- PMLiVE

Leo Pharma’s Enstilar approved by FDA

Topical psoriasistreatment given the green light

- PMLiVE

Can medical technology afford market access?

Medical technologies should be innovative, unique, and have technical feasibility and robust intellectual property. This does not, however, guarantee successful market access and reimbursement.

- PMLiVE

BPL bags FDA approval for rare bleeding disorder therapy

First drug approved for hereditary Factor X deficiency

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links